GSK to donate a billion tablets a year for neglected diseases

Today the World Health Organisation will launch its first report on progress in combatting the neglected tropical diseases that undermine the health of the poor and wreck their life chances. GSK will donate drugs costing £12 million a year, but other companies need to do more GlaxoSmithKline will today commit to donating one billion tablets of its drug albendazole every year, to treat children in poor countries whose growth and learning capacity is threatened by intestinal worms. It’s enough to treat every child in Africa. GSK already gives 600 million tablets for its flagship global health programme against lymphatic filiariasis (also known as elephantiasis), but the same drug works against the worms, called technically “soil transmitted helminths”, that cause stunting and worsen anaemia in children who live in some of the poorest communities on earth, where clean water and good sanitation are not available

Read more from the original source:
GSK to donate a billion tablets a year for neglected diseases